The current diagnostic criterion for IDH mutation status is based on lab tests via surgical tissue samples. APTw and MT imaging contrast mechanisms can detect low-concentration mobile proteins and semi-solid macromolecules, respectively. We implemented a support vector machine (SVM)-based method to predict IDH1/2 genotype in gliomas using APTw and MT MRI features. 105 WHO Grade II and III glioma patients with complete imaging and genetic data were enrolled. Within the supervised classification framework, our results suggest that the use of APTw and MT features enabled the SVM to reach the accurate diagnosis of the IDH genotype in gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords